These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 592338)

  • 1. Antileukemic activity of derivatives of 1-phenyl-2,5-dimethyl-3,4-bis(hydroxymethyl)pyrrole bis(N-methylcarbamate).
    Anderson WK; Corey PF
    J Med Chem; 1977 Dec; 20(12):1691-4. PubMed ID: 592338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antileukemic activity of derivatives of 1,2-dimethyl-3,4-bis(hydroxymethyl)-5-phenylpyrrole bis(N-methylcarbamate).
    Anderson WK; Halat MJ
    J Med Chem; 1979 Aug; 22(8):977-80. PubMed ID: 490542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antileukemic activity of 5-substituted 2,3-dihydro-6,7-bis(hydroxymethyl)-1H-pyrrolizine diesters.
    Anderson WK; Corey PF
    J Med Chem; 1977 Jun; 20(6):812-8. PubMed ID: 874955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of furan, thiophene, and azole bis[(carbamoyloxy)methyl] derivatives as potential antineoplastic agents.
    Anderson WK; Jones AN
    J Med Chem; 1984 Dec; 27(12):1559-65. PubMed ID: 6502590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of antileukemic activity of 5-thienyl- or 5-(2-furyl)-2,3-dihydro-6,7-bis(hydroxymethyl)-1H-pyrrolizine bis(alkylcarbamates) and derivatives.
    Ladurée D; Lancelot JC; Robba M; Chenu E; Mathé G
    J Med Chem; 1989 Feb; 32(2):456-61. PubMed ID: 2913306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antileukemic activity of 1-methyl-2,5-diphenyl-3,4-bis(hydroxymethyl)-, 1,2,3-triphenyl-4,5-bis(hydroxymethyl)-, and 1-methyl-2,3-diphenyl-4,5-bis(hydroxymethyl)pyrrole bis(N-methylcarbamate).
    Anderson WK; Halat MJ; Rick AC
    J Med Chem; 1980 Jan; 23(1):87-9. PubMed ID: 7359518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antileukemic activity of fluorinated analogues of 2,3-dihydro-5-phenyl-6,7-bis(hydroxymethyl)-1H-pyrrolizine biscarbamate.
    Anderson WK; McPherson HL
    J Med Chem; 1982 Jan; 25(1):84-6. PubMed ID: 7086826
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and murine antineoplastic activity of bis[(carbamoyloxy)methyl] derivatives of pyrrolo[2,1-a]isoquinoline.
    Anderson WK; McPherson HL; New JS; Rick AC
    J Med Chem; 1984 Oct; 27(10):1321-5. PubMed ID: 6481769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the chemical reactivities and antineoplastic activities of alpha,beta-, alpha,beta'-, beta,beta'-, and alpha,alpha'-bis[[[(2-propylamino)carbonyl]oxy]methyl]-substituted pyrroles.
    Anderson WK; Heider AR
    J Med Chem; 1986 Nov; 29(11):2392-5. PubMed ID: 3783597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antileukemic activity of bis[[(carbamoyl)oxy]methyl]- substituted pyrrolo[2,1-a]isoquinolines, pyrrolo[1,2-a]quinolines, pyrrolo[2,1-a]isobenzazepines, and pyrrolo[1,2-a]benzazepines.
    Anderson WK; Heider AR; Raju N; Yucht JA
    J Med Chem; 1988 Nov; 31(11):2097-102. PubMed ID: 3184121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antineoplastic activity of bis[[[(alkylamino)carbonyl]oxy]methyl]-substituted 3-pyrrolines as prodrugs of tumor inhibitory pyrrole bis(carbamates).
    Anderson WK; Milowsky AS
    J Med Chem; 1986 Nov; 29(11):2241-9. PubMed ID: 3783586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-Pyrroline N-oxide bis(carbamate) tumor inhibitors as analogues of indicine N-oxide.
    Anderson WK; Milowsky AS
    J Med Chem; 1987 Nov; 30(11):2144-7. PubMed ID: 3669020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, chemical reactivity, and antileukemic activity of 5-substituted 6,7-bis(hydroxymethyl)pyrrolo[1,2-c]thiazole biscarbamates and the corresponding sulfoxides and sulfones.
    Anderson WK; Mach RH
    J Med Chem; 1987 Nov; 30(11):2109-15. PubMed ID: 3669018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of Methyl 2,3-bis(hydroxymethyl)-5-phenyl-7-oxabicyclo[2.2.1]hepta-2,5-diene- 6-carboxylate bis(N-methylcarbamate) derivatives as potential antitumor agents.
    Anderson WK; Mulumba B
    J Pharm Sci; 1984 Aug; 73(8):1182-3. PubMed ID: 6491932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, antineoplastic activity, and chemical properties of bis(carbamate) derivatives of 4,5-bis(hydroxymethyl)imidazole.
    Anderson WK; Bhattacharjee D; Houston DM
    J Med Chem; 1989 Jan; 32(1):119-27. PubMed ID: 2909723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allylic esters as potential antitumor agents. Derivatives and analogues of 2,3-bis(hydroxymethyl)-7-oxabicyclo[2.2.1]hept-2-ene.
    Anderson WK; Dewey RH; Mulumba B
    J Med Chem; 1979 Oct; 22(10):1270-2. PubMed ID: 513076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, structure and cytostatic activity of a series of N-substituted 3,4-diphenyl-1H-pyrrole-2,5-diones.
    Fernández Braña M; Fernández A; Garrido M; López Rodríguez ML; Morcillo MJ; Sanz AM
    Chem Pharm Bull (Tokyo); 1989 Oct; 37(10):2710-2. PubMed ID: 2611930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Diazopyrroles: synthesis and antileukemic activity.
    Cirrincione G; Almerico AM; Diana P; Grimaudo S; Barraja P; Dattolo G; Aiello E; Mingola F
    Farmaco; 1996 Apr; 51(4):275-7. PubMed ID: 8645415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA-Directed alkylating agents. 7. Synthesis, DNA interaction, and antitumor activity of bis(hydroxymethyl)- and bis(carbamate)-substituted pyrrolizines and imidazoles.
    Atwell GJ; Fan JY; Tan K; Denny WA
    J Med Chem; 1998 Nov; 41(24):4744-54. PubMed ID: 9822545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cytotoxicity and mode of action of 2,3,4-trisubstituted pyrroles and related derivatives in human Tmolt4 leukemia cells.
    Gupton JT; Burham BS; Byrd BD; Krumpe KE; Stokes C; Shuford J; Winkle S; Webb T; Warren AE; Barnes CR; Henry J; Hall IH
    Pharmazie; 1999 Sep; 54(9):691-7. PubMed ID: 10522273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.